Drug profile

The FDA adverse-event record for Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Parain

230 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Parain. See the species affected, top reactions, and outcomes below.

230
adverse-event reports
10.9%
death-coded share
Dog
most-reported species
88
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
230
Total Reports
25
Deaths Reported
10.9%
Death Rate

Active Ingredients

Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Parain

Administration Routes

NasalSubcutaneousOral

Species Affected

Dog 230

Most Affected Breeds

Terrier - Bull - American Pit 31
Retriever - Labrador 17
Chihuahua 13
Crossbred Canine/dog 11
Shih Tzu 9
Retriever - Golden 8
Bulldog - French 8
Maltese 7
Terrier (unspecified) 7
Dachshund (unspecified) 6

Most Reported Reactions

Vomiting 88
Facial swelling (see also Skin) 39
Anaphylaxis 35
Lethargy (see also Central nervous system depression in Neurological) 30
Hives (see also Skin) 25
Lethargy (see also Central nervous system depression in 'Neurological') 24
Diarrhoea 23
Facial swelling (see also 'Skin') 21
Emesis (multiple) 18
Death 17
Pale mucous membrane 16
Hypersensitivity reaction 15

Outcome Breakdown

Ongoing
117 (50.9%)
Recovered/Normal
74 (32.2%)
Died
17 (7.4%)
Outcome Unknown
14 (6.1%)
Euthanized
8 (3.5%)

Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Parain Adverse Event Insights

230 reports name Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Parain; 25 recorded a death outcome (10.9% of reported events, not a population-level mortality rate). Active ingredient: Bordetella Bronchiseptica 92B 012992-7 Strain Boehringer Ingelheim;Canine Parain. Administration routes: Nasal, Subcutaneous, Oral.

By species: Dog (230 reports). By breed: Terrier - Bull - American Pit (31), Retriever - Labrador (17), Chihuahua (13).

Leading clinical signs: Vomiting (88), Facial swelling (see also Skin) (39), Anaphylaxis (35), Lethargy (see also Central nervous system depression in Neurological) (30). Outcome, 230 coded reports: Ongoing leads at 50.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.